Evidence map›Paper›PMID 32090131›Full record

ArticleJournal of immunology research2020

Predicting Outcomes of Rat Vascularized Composite Allotransplants through Quantitative Measurement of Chimerism with PCR-Amplified Short Tandem Repeat.

Hui-Yun Cheng, Xiao-Ting Huang, Chih-Fan Lin, Nidal F Al Deek, Ling-Yi Shih, Cheng-Hung Lin, Fu-Chan Wei

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hui-Yun ChengCenter for Vascularized Composite Allotransplantation, Linkou Chang Gung Memorial Hospital, Kueishan Taoyuan 333, Taiwan.ORCID https://orcid.org/0000-0001-5422-2598
Xiao-Ting HuangDepartment of Plastic and Reconstructive Surgery, Linkou Chang Gung Memorial Hospital, Kueishan Taoyuan 333, Taiwan.
Chih-Fan LinCenter for Vascularized Composite Allotransplantation, Linkou Chang Gung Memorial Hospital, Kueishan Taoyuan 333, Taiwan.ORCID https://orcid.org/0000-0002-7529-4475
Nidal F Al DeekCenter for Vascularized Composite Allotransplantation, Linkou Chang Gung Memorial Hospital, Kueishan Taoyuan 333, Taiwan.
Ling-Yi ShihDepartment of Plastic and Reconstructive Surgery, Linkou Chang Gung Memorial Hospital, Kueishan Taoyuan 333, Taiwan.
Cheng-Hung LinCenter for Vascularized Composite Allotransplantation, Linkou Chang Gung Memorial Hospital, Kueishan Taoyuan 333, Taiwan.
Fu-Chan WeiCenter for Vascularized Composite Allotransplantation, Linkou Chang Gung Memorial Hospital, Kueishan Taoyuan 333, Taiwan.
Chang Gung Memorial Hospital · TWChang Gung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chimerism has been associated with the induction and maintenance of tolerance to vascularized composite allotransplants (VCA). Although most VCA studies have examined chimerism using flow cytometry, we proposed that precision in the measurement of chimerism may be better approximated when complimentary polymerase chain reaction (PCR) is applied to a specific short tandem repeat (STR). We identified a STR, D10Rat25, which exhibited a ~20 bp difference in length between two rat strains (BN and LEW) often utilized as the donor and recipient in many allotransplantation studies. D10Rat25 was PCR-amplified and quantified with capillary electrophoresis. With pure LEW and BN DNA, a standard curve was constructed to measure chimerism with good linearity. When applied to rat VCA, the relationship between systematic (in peripheral blood) or local (at specific organ/tissues) chimerism to allograft outcomes was noted. We found that peripheral chimerism was elevated by up to ~9% postoperative month 1 (POM 1) but then reduced regardless of the final VCA outcome. However, differences in VCA skin chimerism between early rejection and POM 1 (shown as

Indexed as

Microsatellite RepeatsPolymerase Chain ReactionTransplantation ChimeraVascularized Composite AllotransplantationAnimalsBase SequenceMalePrognosisRatsSensitivity and SpecificitySequence Analysis, DNATreatment Outcome

Identifiers

PMID32090131
PMCPMC7024101
OpenAlexW3004325501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.